Barely Significant
← all excerpts

Empagliflozin improves insulin sensitivity in patients with recent acute coronary syndrome and newly detected dysglycaemia : Experiences from the randomized, controlled SOCOGAMI trial.

Cardiovasc Diabetol · 2023 · PMC10422806 · PMID 37568149

1
hedged sentence
closest p
boldest claim

The sentences

approached significanceno p-value reported
The Matsuda index also approached significance, with a p value for interaction of 0.052.

also in 8,237 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.